Navigation Links
Florida Man Develops Bladder Cancer as Result of Taking Actos, Alleges Lawsuit Filed by Parker Waichman LLP
Date:6/24/2013

New York, NY (PRWEB) June 24, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs, has filed a lawsuit on behalf of a Florida man who developed bladder cancer after taking the diabetes drug Actos (pioglitazone). The suit was filed on May 23, 2013 in the U.S. District Court for the Western District of Louisiana (Case No. 6:13-cv-1236). It is one of thousands of cases that have been filed into the multidistrict litigation (MDL) entitled In Re: Actos (Pioglitazone) Products Liability Litigation (6:11-md-2299). Takeda Pharmaceuticals, America; Takeda Pharmaceuticals USA, Inc. f/k/a Takeda Pharmaceuticals North America, Inc.; Takeda Pharmaceutical Company Limited; and Eli Lilly and Company have been named as Defendants.

According to the Complaint, the Plaintiff took Actos to treat his Type 2 diabetes from January 2002 to April 2005, when he was diagnosed with bladder cancer. The lawsuit alleges that his bladder cancer was due to the side effects of Actos. Additionally, the suit alleges that the Defendants knew about the risk of bladder cancer but did not disclose this information to consumers in order to protect financial interests. The Plaintiff alleges that Actos caused pain and suffering, emotional distress and economic damages in the form of medical expenses and lost wages. The suit is also seeking damages for loss of consortium on behalf of the Plaintiff’s spouse.

In June 2011, the U.S. Food and Drug Administration (FDA) warned that taking Actos for more than a year could significantly increase the risk of bladder cancer and announced that the label would be updated to reflect this risk. This warning was based on an ongoing 10-year study by Kaiser Permanente. (http://
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Into Action Drug and Alcohol Treatment Center Donates Tiles to RiseUP Gallery in Miami, Florida
2. Florida Lawmakers Agenda Against the Future of Medical and Recreational Marijuana in Florida May Have Severe Repercussions, as Reported by PotStores.com
3. Key West, Florida Joins Best Halfway House Recovery Network, Helping People Seek Further Recovery from Drug and Alcohol Addiction
4. Nemours Pediatric ENT Performs Minimally Invasive Procedure on South Florida Boy at Wolfson Children’s Hospital in Jacksonville, FL
5. Pensacola, Florida Joins Best Halfway House Recovery Network, Providing Resources for Those Seeking to Further Their Recovery from Drug and Alcohol Addiction
6. Florida Athletes Prepare for National Veteran Wheelchair Games in Tampa
7. Controversial Detox Center Billboard Appearing in South Florida
8. The Women’s Board of Wolfson Children’s Hospital Announces 2013-2014 Florida Forum Lineup
9. US Sports Camps Announces NIKE Baseball Camps to Host Two New Camp Locations in Florida
10. South Florida's Most Popular Dermatologist Dr. Flor Mayoral Launches New Website at MayoralDerm.com
11. US Drug Watchdog Now Urges All Florida Recipients of a Recalled DePuy ASR XL Hip Implant to Call Them Immediately if They Have Not Yet Been Identified by a Law Firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... Medical Products, Inc., a Mississippi Corporation, ... GE Healthcare to become an authorized distributor for GE ... MPI has 31 years in distribution within the U.S. ... this agreement, MPI will have the opportunity to extend ... , MPI has always strived to provide our ...
(Date:3/6/2015)... 06, 2015 The Public Health ... five-year accreditation status to seven more health departments. This ... 1.3 million people can now be assured that their ... the health of their communities. , Public health departments ... health of people and communities. Across the nation, health ...
(Date:3/5/2015)... London, UK (PRWEB) March 06, 2015 ... of them being first–in-class. AstraZeneca tops the list scoring ... field obtained over 25% of all FDA approved drug ... total. First-in-class mechanisms such as anti-PCSK9, anti-PD1 and CDK ... have been approved by the FDA to treat metastatic ...
(Date:3/5/2015)... York, NY (PRWEB) March 05, 2015 Shania ... time in more than a decade. She has hinted that ... want to miss seeing her perform one last time. She ... years and this beloved country sweetheart has millions of loyal fans ... touring throughout her native country, Canada, and on June 30th she ...
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned ... awarding the plaintiff Coleen M. Perry a total of $5.7 ... TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., a ... a partner at Wagstaff & Cartmell in Kansas ... along with Rich Freese and Tim Goss of Freese ...
Breaking Medicine News(10 mins):Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 2Health News:Nearly 113 Million U.S. Residents Now Reaping Benefits of National Public Health Department Accreditation 3Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 2Health News:Shania Twain Tickets: Ticket Down Announces Shania Twain's 2015 “Rock This Country” North American Tour 3Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2
... to Simulcast On The N and Nick at Nite Friday, July 11, at ... ... Champion of Fitness, Laila Ali; 12 High School Students Take On the ... Compete For $25,000, NEW YORK, June 18 The N, the network ...
... that made the discovery, Professor Christopher Rowe of the ... presents medical practitioners with the best opportunity to delay ... an experimental stage, this work places Australia at the ... , A 2004 Access Economics report calculated that if ...
... beer and spirits bigger than the standard, study finds , , ... to a bar and assume one drink an hour won,t ... that bartenders pack a lot more booze into common drinks ... and restaurants in Northern California last year and found that ...
... BlueCross,BlueShield of South Carolina Foundation will grant $1.5 ... Carolina,Nurses Foundation, Inc. Distributed over three years, the ... nurses who will then become faculty in,nursing education ... experiencing a serious nursing shortage due to the,retirement ...
... ATSI ), manufacturer and marketer of state-of-the-art ... at the Piper,Jaffray Europe Conference in London, England ... CEO of ATS Medical will present at 9:00 ... Attendance at the conference is by invitation only. ...
... 18 Georgetown University, Gentag,Inc., and Science ... forces to develop a non-invasive method for ... combine their,respective intellectual property (IP) and expertise ... using disposable skin patches with wireless sensors ...
Cached Medicine News:Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 2Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 3Health News:The N Shapes Up This Summer With the New One-Hour Teen Reality Series, The N's Student Body 4Health News:Advance towards early Alzheimer's diagnosis 2Health News:Bar Drinks Pack More Punch Than Thought 2Health News:BlueCross' $1.5 Million Nursing Scholarships to Ease Nursing Faculty Shortage 2Health News:BlueCross' $1.5 Million Nursing Scholarships to Ease Nursing Faculty Shortage 3Health News:ATS Medical to Participate at the Piper Jaffray Europe Conference 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 2Health News:No More Needles? Georgetown University Teams with Gentag and SAIC to Develop New Glucose Sensor Technology with Wireless Connection to Cell Phones 3
(Date:3/6/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... million milestone payment from Biogen Idec related to advancing ... in infants with spinal muscular atrophy (SMA).  ... Rx, is a randomized, double-blind, sham-procedure controlled thirteen ... The study will evaluate the efficacy and safety of ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx ... clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and ... has commenced an underwritten public offering of American ... its Ordinary Shares. All of the ADSs in ... JMP Securities is acting as ...
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2
... Siemens Medical Solutions, Solidifies Its ... HOFFMAN ESTATES, Ill., Sept. 10 The ... words," but that value is undoubtedly higher,in ... years of,work. Siemens Medical Solutions, Molecular Imaging ...
... log10 (>99%) Mean HCV RNA Decrease with No ... Serious Adverse Events - ... -, PRINCETON, N.J., Sept. 10 Pharmasset, Inc.,(Nasdaq: VRUS ) reports ... 40 patients chronically,infected with hepatitis C virus (HCV) who have failed prior interferon,therapy. ...
Cached Medicine Technology:Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 2Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 3Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 4Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 2R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 3R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 4R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 5R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients 6
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: